A PYMNTS Company

Morocco Fines US Pharma Firm Viatris Over Merger Notification Breach

 |  November 21, 2024

U.S. pharmaceutical company Viatris has been fined 7.58 million dirhams ($760,000) by Morocco’s competition authority for failing to notify the regulator of its merger, according to two anonymous sources cited by Reuters. The fine stems from the company’s 2020 formation through the merger of Mylan, which operates a subsidiary in Morocco, and Pfizer’s Upjohn division.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    The penalty, amounting to 2.5% of Viatris’ revenue in Morocco for the previous year, has already been paid into the Moroccan treasury, the sources confirmed. They also indicated that Viatris has chosen not to appeal the decision. The company has not provided a response to Reuters’ request for comment on the matter.

    The Moroccan competition authority is now widening its scrutiny to examine other mergers that may have bypassed mandatory notification requirements. This includes a joint venture involving OCP, a leading phosphate and fertilizer producer, and Fertinagro Biotech, as well as the acquisition of Whirlpool’s Middle East and North Africa operations by Turkish appliance manufacturer Arcelik, one of the sources added.

    Related: PBMs Push Back Against FTC, Filing Lawsuit Over Regulatory Actions

    The case highlights Morocco’s increasing enforcement of antitrust regulations in a bid to ensure transparency and fair competition in its markets.

    Viatris, which has a significant global presence, was established to enhance access to medicines worldwide. However, this recent development underscores the importance of adhering to local regulatory frameworks in international markets.

    Source: Reuters